Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Lower extremity peripheral artery disease (PAD) affects> 230 million adults worldwide and is
associated with increased risk of various adverse clinical outcomes (other cardiovascular …

Background Peripheral artery disease is a major cardiovascular disease that affected 202
million people worldwide in 2010. In the past decade, new epidemiological data on …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Approximately 6% of adults worldwide have atherosclerosis and thrombosis of the lower
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Peripheral artery disease (PAD) stems from atherosclerosis of lower extremity arteries with
resultant arterial narrowing or occlusion. The most severe form of PAD is termed chronic …

Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Aims The atherogenic potential of cholesterol in triglyceride-rich lipoproteins, also called
remnant cholesterol, is being increasingly acknowledged. Elevated remnant cholesterol is …